The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
- PMID: 28011307
- PMCID: PMC5972535
- DOI: 10.1016/j.nbd.2016.12.013
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Abstract
Olfactory deficits are present in numerous neurodegenerative disorders and are accompanied by pathology in related brain regions. In several of these disorders, olfactory disturbances appear early and are considered as prodromal symptoms of the disease. In addition, pathological protein aggregates affect olfactory regions prior to other regions, suggesting that the olfactory system might be particularly vulnerable to neurodegenerative diseases. Exposed to the external environment, the olfactory epithelium and olfactory bulb allow pathogen and toxin penetration into the brain, a process that has been proposed to play a role in neurodegenerative diseases. Determining whether the olfactory bulb could be a starting point of pathology and of pathology spread is crucial to understanding how neurodegenerative diseases evolve. We argue that pathological changes following environmental insults contribute to the initiation of protein aggregation in the olfactory bulb, which then triggers the spread of the pathology within the brain by a templating mechanism in a prion-like manner. We review the evidence for the early involvement of olfactory structures in neurodegenerative diseases and the relationship between neuropathology and olfactory function. We discuss the vulnerability and putative underlying mechanisms by which pathology could be initiated in the olfactory bulb, from the entry of pathogens (promoted by increased permeability of the olfactory epithelium with aging or inflammation) to the sensitivity of the olfactory system to oxidative stress and inflammation. Finally, we review changes in protein expression and neural excitability triggered by pathogenic proteins that can promote pathogenesis in the olfactory bulb and beyond.
Keywords: Alpha-synuclein; Alzheimer's disease; Beta-amyloid; Neuroinflammation; Olfactory system; Parkinson's disease; Synucleinopathies; TDP-43; Tau; Tauopathies.
Copyright © 2016 Van Andel Research Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors declare no other conflicts of financial interests.
Figures
References
-
- Abele M, Riet A, Hummel T, Klockgether T, Wüllner U. Olfactory dysfunction in cerebellar ataxia and multiple system atrophy. J Neurol. 2003;250:1453–1455. http://dx.doi.org/10.1007/s00415-003-0248-4. - DOI - PubMed
-
- Adler CH, Connor DJ, Hentz JG, Sabbagh MN, Caviness JN, Shill HA, Noble B, Beach TG. Incidental Lewy body disease: clinical comparison to a control cohort. Mov Disord. 2010;25:642–646. http://dx.doi.org/10.1002/mds.22971. - DOI - PMC - PubMed
-
- Aguzzi A, Baumann F, Bremer J. The Prion’s elusive reason for being. Annu Rev Neurosci. 2008;31:439–477. http://dx.doi.org/10.1146/annurev.neuro.31.060407.125620. - DOI - PubMed
-
- Ahlskog JE, Waring SC, Petersen RC, Esteban-Santillan C, Craig UK, O’Brien PC, Plevak MF, Kurland LT. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology. 1998;51:1672–1677. - PubMed
-
- Alavi Naini SM, Soussi-Yanicostas N. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies? Oxidative Med Cell Longev. 2015;2015:151979. http://dx.doi.org/10.1155/2015/151979. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
